William Steinkrauss
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von William Steinkrauss
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Holding Company | Pharmaceuticals: Major | 40 | |
14
| Public Company | Biotechnology | 14 |
OvaScience, Inc.
 OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA.
10
| Extinct | Pharmaceuticals: Major | 10 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von William Steinkrauss
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| KALEIDO BIOSCIENCES, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer Investor Relations Contact Chief Administrative Officer | |
| AMAG PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Administrative Officer Director of Finance/CFO Compliance Officer | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | General Counsel Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Sales & Marketing Corporate Officer/Principal | |
| TESARO INC | Pharmaceuticals: Major | General Counsel Founder Corporate Officer/Principal Chief Administrative Officer | |
| TREVENA, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Chief Executive Officer | |
| TETRAPHASE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Sales & Marketing Chief Executive Officer Corporate Officer/Principal | |
| LA JOLLA PHARMACEUTICAL COMPANY | Pharmaceuticals: Major | Sales & Marketing Chief Executive Officer Corporate Officer/Principal | |
| Boston University | College/University | Undergraduate Degree Director/Board Member Masters Business Admin | |
| X4 PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer | |
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal General Counsel | |
| University of Massachusetts | College/University | Undergraduate Degree Masters Business Admin Undergraduate Degree | |
Optimer Pharmaceuticals LLC
 Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| NABRIVA THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | College/University | Graduate Degree Masters Business Admin | |
| DIMENSION THERAPEUTICS INC | Biotechnology | Director of Finance/CFO Director/Board Member | |
| INHIBIKASE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| AKEBIA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Investor Relations Contact | |
| XILIO THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Operating Officer Chief Executive Officer | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree | |
| SPERO THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Operating Officer | |
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
| DIANTHUS THERAPEUTICS, INC. | Biotechnology | Chairman Director/Board Member | |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Undergraduate Degree Doctorate Degree | |
| Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Investment Trusts/Mutual Funds | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Wisconsin | College/University | Corporate Officer/Principal Undergraduate Degree | |
| F2g Inc. | Director/Board Member President | ||
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| University of Rochester Simon Business School | College/University | Masters Business Admin Masters Business Admin | |
F2G Ltd.
 F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
| AVANIR PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| EPIRUS BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Chief Operating Officer | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| COLUCID PHARMACEUTICALS INC | Biotechnology | Director/Board Member Director/Board Member | |
BioTheryX, Inc.
 BioTheryX, Inc. Pharmaceuticals: MajorHealth Technology BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Temple University (Pennsylvania) | College/University | Director/Board Member Undergraduate Degree | |
| University of Vermont | College/University | Undergraduate Degree Doctorate Degree | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal |
Statistik
International
| Vereinigte Staaten | 48 |
| Irland | 2 |
| Vereinigtes Königreich | 2 |
Sektoral
| Health Technology | 36 |
| Consumer Services | 12 |
| Miscellaneous | 2 |
| Commercial Services | 2 |
Operativ
| Director/Board Member | 296 |
| Corporate Officer/Principal | 169 |
| Independent Dir/Board Member | 108 |
| Undergraduate Degree | 58 |
| Chief Tech/Sci/R&D Officer | 51 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Michael Bonney | 32 |
| Robert Perez | 31 |
| Lonnie Moulder | 31 |
| Patrick Volkert Vink | 30 |
| Mark Corrigan | 29 |
| Lori Kunkel | 27 |
| Steven Gilman | 25 |
| Alison Lawton | 24 |
| Jane Ellen Henney | 20 |
| John P. Howe | 20 |
| Nancy Hutson | 19 |
| John Hohneker | 19 |
| David McGirr | 16 |
| Mary Thistle | 16 |
| Mani Mohindru | 15 |
- Börse
- Insiders
- William Steinkrauss
- Unternehmensverbindungen
